Zhe Jiang Hai Liang Co., Ltd (SHE:002203)

Market Cap	22.85B
Revenue (ttm)	86.07B
Net Income (ttm)	733.12M
Shares Out	1.92B
EPS (ttm)	0.37
PE Ratio	32.55
Forward PE	18.31
Dividend	0.18 (1.51%)
Ex-Dividend Date	Jul 4, 2025

Volume	122,719,725
Average Volume	17,231,972
Open	10.81
Previous Close	10.96
Day's Range	10.81 - 12.06
52-Week Range	7.60 - 12.06
Beta	0.32
RSI	74.79
Earnings Date	Aug 30, 2025

About Regulus Therapeutics

Zhe Jiang Hai Liang Co., Ltd engages in the production, sale, and service of copper products, materials of conductors, and aluminum-based materials. Its products include copper coil tubes, straight tubes, fittings, copper and brass bars, copper bus bars, aluminum tubes, denitration catalysts, and other equipment. The company’s products are used in household appliance, equipment and instrument, ship, electricity, new energy vehicles, energy storage, photovoltaic, wind energy, semiconductor, 5G communication, and others. Zhe Jiang Hai Liang Co., ...

• Industry: Copper
• Sector: Materials
• Founded: 2001
• Employees: 10,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002203

Financial Performance

In 2024, Zhe Jiang Hai Liang's revenue was 87.39 billion, an increase of 15.61% compared to the previous year's 75.59 billion. Earnings were 703.30 million, a decrease of -37.10%.